The aim of the project is to use methods and processes of the Medical Informatics Initiative (MII) to contribute to the detection of health risks in patients with polypharmacy. Polypharmacy occurs especially in elderly patients with multimorbidity. Polypharmacy associated with an increased risk for medication errors and drug-drug or drug-disease interactions, which either reduce or intensify the desired effect of individual active substances or lead to undesired adverse drug effects (ADE). In the
Autoren bzw. Ansprechpartner für diesen Datensatz sind:
Universität Bonn: Anna Böhmer, Prof. Ulrich Jaehde
Universitätsklinikum Bonn: Katharina Karsten Dafonte, Dr. med. Martin Coenen, Prof. Hartmann Bonn: Fr. Karsten Dafonte, Dr. med. Coenen, Prof. Hartmann
The medical informatics initiative was created to close the gap between research and healthcare. All of Germany’s university hospitals have joined forces with research institutions, businesses, health insurers, and patient advocacy groups to create a framework that harnesses research findings to the direct benefit of patients. The German Federal Ministry of Education and Research (BMBF) is investing around 160 million euros in the programme through 2021.
The digitisation of medicine is creating
The Health Atlas is an alliance of medical ontologists, medical systems
biologists and clinical trials groups to design and implement a multi-functional and quality-assured
atlas. It provides models, data and metadata on specific use cases from medical research fields.